- Home
- BCYC vs KIO Comparison
BCYC vs KIO Comparison
Compare BCYC & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- KIO
- Stock Information
- Founded
- BCYC 2009
- KIO 2011
- Country
- BCYC United Kingdom
- KIO United States
- Employees
- BCYC N/A
- KIO 2400
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- KIO Investment Managers
- Sector
- BCYC Health Care
- KIO Finance
- Exchange
- BCYC Nasdaq
- KIO Nasdaq
- Market Cap
- BCYC 511.4M
- KIO 475.7M
- IPO Year
- BCYC 2019
- KIO N/A
- Fundamental
- Price
- BCYC $7.39
- KIO $11.45
- Analyst Decision
- BCYC Buy
- KIO
- Analyst Count
- BCYC 8
- KIO 0
- Target Price
- BCYC $29.14
- KIO N/A
- AVG Volume (30 Days)
- BCYC 438.9K
- KIO 136.5K
- Earning Date
- BCYC 05-01-2025
- KIO 01-01-0001
- Dividend Yield
- BCYC N/A
- KIO 10.82%
- EPS Growth
- BCYC N/A
- KIO N/A
- EPS
- BCYC N/A
- KIO N/A
- Revenue
- BCYC $35,275,000.00
- KIO N/A
- Revenue This Year
- BCYC N/A
- KIO N/A
- Revenue Next Year
- BCYC $0.27
- KIO N/A
- P/E Ratio
- BCYC N/A
- KIO N/A
- Revenue Growth
- BCYC 30.76
- KIO N/A
- 52 Week Low
- BCYC $6.10
- KIO $10.52
- 52 Week High
- BCYC $28.67
- KIO $13.59
- Technical
- Relative Strength Index (RSI)
- BCYC 40.27
- KIO 39.01
- Support Level
- BCYC $6.10
- KIO $11.15
- Resistance Level
- BCYC $8.00
- KIO $11.54
- Average True Range (ATR)
- BCYC 0.61
- KIO 0.27
- MACD
- BCYC 0.14
- KIO -0.01
- Stochastic Oscillator
- BCYC 46.07
- KIO 46.34
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.